STEVEN DAMON – CEO of Micron Biomedical As CEO of Atlanta-based Micron Biomedical, Steven Damon leads a team of scientists and innovators to accelerate access to life-saving vaccines and therapeutics globally. Mr. Damon has over 30 years of global leadership experience with various business roles in the medical device and pharmaceutical industries. He founded 4P Therapeutics (sold to Nutriband) and Absorbable Polymers International (a subsidiary of DURECT). In addition, Steven held executive positions with Kimberly-Clark, DURECT, Altea Therapeutics, and Femasys. He serves as chairman of the board of directors for Georgia Bio and as director for Temple Therapeutics.